Semaglutide is significantly more expensive than generic statins, with costs varying considerably depending on insurance coverage, dose, and formulation
Most other injections, like Semaglutide, only target GLP-1
The gap is narrowing as newer GLP-1 and multi-receptor agonist medications are developed
Wegovy (2.4 mg) : Approximately $1,349.02 per month
And even with the immense amount of innovation and R&D dollars being poured into this market, additional challenges remain: Side effects and tolerability concerns remain substantial
Need or prefer in-person medical supervision: Some patients - particularly those with complex medical histories, multiple medications, or conditions requiring physical examination - may benefit more from working with an in-person obesity medicine specialist or endocrinologist